Rchr
J-GLOBAL ID：201801006116463365
Update date: Aug. 22, 2024
Fujioka Kazuki
フジオカ カズキ | Fujioka Kazuki
Affiliation and department：
Research field (2)：
Allergies and connective tissue disease
, Immunology
Research theme for competitive and other funds (4)：
- 2022 - 2025 Analysis of epigenetic regulation of allergic predisposition
- 2021 - 2024 Development of novel cell therapy for autoimmune diseases using iPS cell-derived tolerogenic dendritic cells
- 2019 - 2021 Elucidation of adipose-derived chronic inflammation via adipose tissue-mast cell interaction
- 2016 - 2018 Role of mast cells in adipose-derived chronic inflammation
Papers (16)：
-
Hideaki Sofue, Takashi Kida, Aiko Hirano, Satoshi Omura, Masatoshi Kadoya, Daiki Nakagomi, Yoshiyuki Abe, Naoho Takizawa, Atsushi Nomura, Yuji Kukida, et al. Optimal dose of intravenous cyclophosphamide during remission induction therapy in ANCA-associated vasculitis: A retrospective cohort study of J-CANVAS. Modern rheumatology. 2024. 34. 4. 767-774
-
Satoshi Omura, Takashi Kida, Hisashi Noma, Hironori Inoue, Hideaki Sofue, Aki Sakashita, Masatoshi Kadoya, Daiki Nakagomi, Yoshiyuki Abe, Naoho Takizawa, et al. Effectiveness of intravenous methylprednisolone pulse in patients with severe microscopic polyangiitis and granulomatosis with polyangiitis. Rheumatology (Oxford, England). 2024
-
Aiko Hirano, Kazuki Fujioka, Takashi Kida, Satoshi Omura, Hideaki Sofue, Aki Sakashita, Tomoya Sagawa, Yu Isoda, Akiko Kasahara, Risa Sagawa, et al. Association between early immunophenotypic changes and therapeutic response of belimumab in patients with systemic lupus erythematosus. Lupus. 2023. 32. 1. 63-73
-
Kazuki Fujioka, Akiko Kasahara, Takashi Kida, Wataru Fujii, Takahiro Seno, Makoto Wada, Masataka Kohno, Yutaka Kawahito. Effectiveness and safety of allergen immunotherapy in patients with allergic rhinitis complicated by rheumatic autoimmune diseases: a case series study. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology. 2022. 18. 1. 63-63
-
Shunya Kaneshita, Takashi Kida, Makoto Yoshioka, Keisuke Nishioka, Mithun Raje, Aki Sakashita, Aiko Hirano, Tomoya Sagawa, Akiko Kasahara, Takuya Inoue, et al. CG223, a novel BET inhibitor, exerts TGF-β1-mediated antifibrotic effects in a murine model of bleomycin-induced pulmonary fibrosis. Pulmonary pharmacology & therapeutics. 2021. 70. 102057-102057
ｍore...
Professional career (1)：
Return to Previous Page
